莫菲特癌症中心组织扩张器乳房再造经验:脱细胞真皮基质是否增加重返手术室风险?
回顾性分析2010年11月至2016年11月莫菲特癌症中心756例组织扩张器联合假体乳房再造病例,其中组织扩张器联合脱细胞真皮基质(ADM)组53例、单纯组织扩张器组703例。ADM组重返手术室风险约为单纯组的3倍(7.5% vs 2.4%),且ADM组更常需3次及以上后续组织扩张器置入(54.7% vs 4.8%,P<0.0001)。作者认为ADM可用于特定患者,但在组织扩张器乳房再造中应审慎选择。
要点
- ADM组重返手术室率为7.5%,单纯组织扩张器组为2.4%,ADM组风险约为单纯组的3倍。
- ADM组54.7%需3次及以上后续组织扩张器置入,单纯组为4.8%(P<0.0001)。
- 作者认为ADM可用于特定患者,但在组织扩张器乳房再造中应审慎选择。
核心结论
- ADM可能适用于特定患者,但在组织扩张器乳房再造中应审慎选择,因为观察到需重返手术室的并发症增加。
研究设计与样本
- 经机构审查委员会批准,对2010年11月至2016年11月莫菲特癌症中心2位乳房再造外科医生的756例组织扩张器联合假体病例进行回顾性病历审查。
- 患者分为两组:单纯组织扩张器再造组(TE)和组织扩张器联合ADM组(TE+ADM)。
主要发现
- TE组703例,TE+ADM组53例。
- TE+ADM组重返手术室率为7.5%,TE组为2.4%,TE+ADM组重返手术室风险约为TE组的3倍。
- TE+ADM组54.7%需3次及以上后续组织扩张器置入,TE组为4.8%(P<0.0001)。
关键数值与推荐
- 并发症定义为因冲洗和清创以及后续组织扩张器置入而重返手术室。
临床怎么用
- 作者认为ADM可用于特定患者,但在组织扩张器乳房再造中应审慎选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tissue expander and implant remains the most common technique for breast reconstruction. A controversial topic within this method is routine use of acellular dermal matrix (ADM). Acellular dermal matrices have increased risks of infection, seroma, hematoma, skin flap necrosis, and total complications. METHODS: After an institutional review board approval, a retrospective chart review was conducted of 756 tissue expander with implant cases from November 2010 to November 2016 at Moffitt Cancer Center with 2 breast reconstruction surgeons. Patients were grouped in 2 groups: tissue expander alone reconstruction (TE) and tissue expander with ADM (TE + ADM). Complications were defined by return visits to the operating room for irrigation and debridement as well as for subsequent tissue expander placement. RESULTS: There were 703 patients in the TE group and 53 in the TE + ADM group. Patients undergoing TE + ADM reconstruction were 3 times more likely to experience return to operating room compared with patients undergoing TE alone (7.5% vs 2.4%). Patients were significantly more likely to undergo 3 or more subsequent tissue expander placement procedures with TE + ADM (54.7%) compared with TE alone (4.8%) (P < 0.0001). CONCLUSIONS: Although ADM may be appropriate for specific patients, its use in tissue expander breast reconstruction should be judiciously selected, because there is an observed increase in complications needing return to the operating room.
引用
- Weinstein B, Kumar A, Smith P, et al. Moffitt Cancer Center Experience of Tissue Expander Breast Reconstruction: Does Acellular Dermal Matrix Increase Return to the Operating Room? Ann Plast Surg. 2018. PMID: 29369110. doi:10.1097/SAP.0000000000001322
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。